Safety and Efficacy of Current DAA Regimens in Kidney and Liver Transplant Recipients with Hepatitis C: Results from the HCV-TARGET Study

BACKGROUND: Data outside of clinical trials with direct acting antiviral (DAA) regimens with or without ribavirin as treatment of chronic HCV in solid organ transplant recipients is limited. METHODS: Liver transplant (LT), kidney transplant (KT) and dual liver kidney (DLK) transplant recipients from...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hepatology
Main Authors: Saxena, Varun, Khungar, Vandana, Verna, Elizabeth C., Levitsky, Josh, Brown, Robert S., Hassan, Mohamed A., Sulkowski, Mark S., O’Leary, Jacqueline G., Koraishy, Farrukh, Galati, Joseph S., Kuo, Alexander A., Vainorius, Monika, Akushevich, Lucy, Nelson, David R., Fried, Michael W., Terrault, Norah, Reddy, K.Rajender
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5756478/
https://ncbi.nlm.nih.gov/pubmed/28504842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.29258
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados